Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$2.01M Sell
11,657
-91
-0.8% -$14.8K 0.23% 51
2017
Q1
$1.93M Buy
11,748
+1,102
+10% +$183K 0.23% 53
2016
Q4
$1.56M Buy
10,646
+54
+0.5% +$8.13K 0.19% 66
2016
Q3
$1.77M Buy
10,592
+1,871
+21% +$316K 0.23% 52
2016
Q2
$1.33M Sell
8,721
-143
-2% -$22.2K 0.18% 75
2016
Q1
$1.33M Buy
+8,864
New +$1.32M 0.19% 72
2014
Q2
Sell
-3,023
Closed -$373K 441
2014
Q1
$373K Sell
3,023
-65
-2% -$7.88K 0.07% 228
2013
Q4
$352K Sell
3,088
-1,601
-34% -$182K 0.07% 230
2013
Q3
$525K Buy
4,689
+1,067
+29% +$116K 0.11% 140
2013
Q2
$357K Buy
+3,622
New +$376K 0.08% 181

Other funds holding AMGN

1st Global Advisors's AMGN Position: Q2 2017 in Review

1st Global Advisors reduced its Amgen (AMGN) stake by 0.77% in Q2 2017, selling an estimated $14.8K and leaving 11,657 shares worth $2.01M. The position accounts for 0.23% of the portfolio, ranked #51.

1st Global Advisors first reported a position in AMGN in Q2 2013 and has held it in 10 quarters since. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • 1st Global Advisors held 11,657 shares of Amgen worth $2.01M as of Q2 2017.
  • 1st Global Advisors sold 91 Amgen shares in Q2 2017, an estimated $14.8K.
  • Amgen made up 0.23% of 1st Global Advisors's portfolio in Q2 2017, its #51 holding.
  • 1st Global Advisors first reported a position in Amgen in Q2 2013 and has held it in 10 quarters since.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on 1st Global Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.